Interdisciplinary Care Teams in Epilepsy Care: Lucretia Long, APRN-CNP
The associate clinical professor of neurology at OSU Wexner Medical Center discussed the state of interdisciplinary care for individuals with epilepsy, and how these care teams operate. [WATCH TIME: 2 minutes]
WATCH TIME: 4 minutes
“It has a dramatic improvement in overall outcomes for patients and families with epilepsy, and I think we can look at minimizing ER visits, and quality parameters like patient satisfaction. Patients with epilepsy have a lot of challenges with transportation, so if you can incorporate a single visit with that multidisciplinary team, where everyone is there providing appropriate and comprehensive care, you can [provide] a more efficient process and also minimize traveling expenses.”
At the
Lucretia Long, APRN-CNP, an associate clinical professor of neurology at OSU Wexner Medical Center, was among those presenters, offering her perspective on the role of the nurse practitioner in epilepsy care and summarizing her career path to this point. In a conversation with NeurologyLive®, she spoke about the current layout of the interdisciplinary care team at her institution, and the advantages that brings to care.
She specifically highlighted the role that the pharmacy department at OSU Wexner Medical Center plays, assisting with providing patient history and medication counseling for those individuals who have comorbidities or are on multiple therapies. Additionally, she explained what she sees as the biggest challenges to assembling these care teams, including the financial burden and the need to manage the timing of getting all of these members in the same place at the same time to ensure positive communication.
REFERENCE
1. Long L. Career Pathways: Interprofessional Panel: Academic Appointment and Research. Presented at: AES Annual Meeting; December 2-6, 2022; Nashville, TN, and virtual. Professional development.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.